508 filings
Page 25 of 26
DEF 14A
h4cu9pm
28 Apr 05
Definitive proxy
12:00am
10-K
fnamj38v 3n
30 Mar 05
Annual report
12:00am
8-K
7kk3r rxl7mouudw9zv
15 Feb 05
Results of Operations and Financial Condition
12:00am
8-K
rx7dnzittg n8c
10 Feb 05
Entry into a Material Definitive Agreement
12:00am
REGDEX
g51ji
18 Jan 05
Notice of sale of securities
12:00am
8-K
hsn69
3 Jan 05
Unregistered Sales of Equity Securities
12:00am
8-K
y49wn2z4q5 heut
28 Dec 04
Entry into a Material Definitive Agreement
12:00am
8-K
0ob20sls
10 Nov 04
Alnylam Pharmaceuticals Reports Third Quarter 2004 Financial Results
12:00am
8-K
pz3icwcrvw5411kwa
4 Nov 04
Entry into a Material Definitive Agreement
12:00am
8-K
s06 g8hk6nu
4 Oct 04
Departure of Directors or Principal Officers
12:00am
10-Q
0kood01a4k
12 Aug 04
Quarterly report
12:00am
8-K
453w5o7fjru26vu
4 Aug 04
Alnylam Pharmaceuticals Reports Second Quarter 2004 Financial Results
12:00am
8-K
zm9vvkid1hcqss
2 Jul 04
Merck and Alnylam Establish New Strategic Alliance to Co-Develop and Co-Commercialize RNAi Therapeutics for Ocular Diseases
12:00am
S-8
44f2li2fk6wrrgzx rgv
3 Jun 04
Registration of securities for employees
12:00am
8-A12G/A
kpu6eg7667l7nyohr
3 Jun 04
Registration of securities (amended)
12:00am
424B4
t6g9gje quif
28 May 04
Prospectus supplement with pricing info
12:00am